Frequent TP53-inactivating mutations, higher expression of stemness markers (KRT19 and EPCAM) and the tumor marker BIRC5, and activated Wnt and Akt signaling pathways were also reported to associate with stratification of HCC samples (Ally et al., 2017). This evidence concerns the gene TP53 and hepatocellular carcinoma.